Leading Innovation in Clinical Trials
Transforming lives with advanced clinical trials for all.
About The Oakland Institute of Health Inc.
Our Mission
Our mission is to improve the health and well-being of communities with unmet needs by fostering scientific innovation and conducting clinical trials to accelerate the development and availability of effective treatments.
Vision Statement
At The Oakland Institute of Health Inc., we are dedicated to serving a diverse clientele, including private enterprises and government entities. Our commitment to excellence is reflected in our innovative clinical research services, which are tailored to meet the unique needs of our clients while ensuring full compliance with U.S. industry regulations and guidelines.
Our Services
We conduct cutting-edge clinical trials to accelerate the discovery and development of new treatments. By participating in these trials, patients gain access to the latest advancements in healthcare.
Core Values
Patient-Centered Care
We prioritize the well-being and safety of patients in every aspect of our research and healthcare services, ensuring that their needs remain at the forefront of our mission.
Accessibility & Affordability
We strive to make high-quality healthcare and clinical research accessible and affordable, bridging gaps in care and ensuring equitable opportunities for all.
Innovation in Healthcare
We embrace cutting-edge research, emerging technologies, and novel methodologies to advance healthcare solutions and improve patient outcomes.
Community Engagement
We actively collaborate with communities to foster trust, promote health education, and create meaningful partnerships that drive positive change.
Excellence in Clinical Services
We uphold the highest standards of quality, integrity, and compliance in clinical research, ensuring reliable and impactful contributions to medical science.
Welcome to The Oakland Institute of Health Inc.
As part of our strategic growth initiative, we merged with MacArthur Gastroenterology, Inc., enhancing our ability to engage in clinical trials specializing in gastroenterology. This partnership strengthens our expertise and broadens our impact in advancing innovative treatments in digestive health.
Clinical Trial Growth
The clinical trials market is experiencing substantial growth, with a valuation of USD 47.80 billion in 2023, and projections indicating a rise to USD 79.55 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.83% during the forecast period from 2024 to 2032. This growth can be attributed to several key factors, including globalization and an increasing focus on the development of innovative products and therapies.